[Drug therapy of neck-shoulder-arm syndrome].
D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D020968:Brachial Plexus Neuritis / Q000188:drug therapy*; D005753:Gastric Mucosa / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects; D006207:Half-Life; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced; D010423:Pentazocine / Q000627:therapeutic use; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy*; D013993:Tilidine / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D001569:Benzodiazepines; D013993:Tilidine; D010423:Pentazocine
Medikamentöse Therapie des Nacken-Schulter-Arm-Syndroms.